Elevated bioactive prolactin levels in systemic lupus erythematosus - Association with disease activity

Journal of Rheumatology

Volumn 28, Issue 10, 2001, Pages 2216-2221

  Pacilio, M ^a   Migliaresi, S ^a   Meli, R ^a   Ambrosone, L ^a   Bigliardo, B ^a   Di Carlo, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bioactive prolactin; Disease activity; Immunoactive prolactin; Systemic lupus erythematosus

Indexed keywords

PROLACTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOASSAY; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPROLACTINEMIA; IMMUNORADIOMETRIC ASSAY; LYMPHOMA CELL LINE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RASH; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANIMALS; BIOLOGICAL ASSAY; FEMALE; HUMANS; HYPERPROLACTINEMIA; IMMUNORADIOMETRIC ASSAY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOMA; MALE; MIDDLE AGED; PREVALENCE; PROLACTIN; RATS; SEVERITY OF ILLNESS INDEX; TUMOR CELLS, CULTURED;

EID: 0034795663     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Effects of growth hormone and prolactin. Immune development and function
2. Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects
3. Immunoregulatory properties of growth hormone and prolactin
4. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus
5. Hyperprolactinemia in systemic lupus erythematosus: Association with disease activity
6. Hyperprolactinemia in multiple sclerosis
7. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity
8. Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia
9. High serum prolactin levels in asymptomatic HIV-infected patients and in patients with acquired immunodeficiency syndrome
10. Prolactin as a marker of rejection in human heart transplantation
11. Prolactin levels in men with SLE and RA
12. Prolactin in systemic lupus erythematosus
13. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus
14. Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations
15. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases
16. Hyperprolactinemia in systemic lupus erythematosus?
17. Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients
18. Prolactin serum levels and disease activity in systemic lupus erythematosus patients
19. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus
20. Plasma homovanillic acid and prolactin in systemic lupus erythematosus
21. Prolactin levels in patients with systemic lupus erythematosus: A case controlled study
22. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia
23. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis
24. Hyperprolactinemia in males with systemic lupus erythematosus
25. Hyperprolactinemia, uveitis, and systemic lupus erythematosus: Clinical-immunological correlation
26. Basal and after-stimuli test for prolactinemia in systemic lupus erythematosus
27. A new microbioassay for the measurement of lactogenic hormones in human serum
28. Prolactin bioassay and hyperprolactinemia
29. Effects of anti-prolactin autoantibodies on serum prolactin measurements
30. A new sensitive and specific bioassay for lactogenic hormones: Measurement of prolactin and growth hormone in human serum
31. Correlation and comparison of Nb2 lymphoma cell bioassay with radioimmunoassay for human prolactin
32. Euprolactinemic galactorrhea response of bioassayable prolactin to thyrotropin-releasing hormone
33. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
34. The lupus activity criteria count (LACC)
35. Derivation of SLEDAI. A disease activity index for lupus patients
36. Prolactin: Hyperprolactinemic syndromes and management
37. Chloroquine affects prolactin secretion and Golgi morphology in the mammotroph
38. Prolactin, a pituitary hormone that modifies immune responses
39. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power
40. Hormonal profiles and immunological studies of male lupus in Taiwan
41. Rat lymphoma cell bioassay for prolactin: Observations on its use and comparison with radioimmunoassay
42. Correlation of Nb2 bioassay and radioimmunoassay values for human serum prolactin
43. Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: Antiproliferative versus anticytolytic effects
44. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease
45. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease
46. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: An autocrine growth factor for lymphoproliferation
47. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus
48. Interleukin-6 stimulates anterior pituitary hormone release in vitro
49. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus
50. Bromocriptine in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled study